Inventor · disambiguated record
Christopher Tenhoor
Also filed as: TENHOOR CHRISTOPHER
14 granted patents·9 pending applications·118 citations·filing 2009–2023
93Inventor score
Files withDYAX CORP11TAKEDA PHARMACEUTICALS CO8TENHOOR CHRISTOPHER2SEXTON DANIEL J1SYNTONIX PHARMACEUTICALS INC1
Top patents by PatentIndex Score
23 records- 0195US11084884B2Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedemaTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Aug 10, 2021·23 cites·17 claims
- 0295US9260520B2Antibodies to FeRn and uses thereofDYAX CORP·Filed 2014·Granted Feb 16, 2016·18 cites·6 claims
- 0394US8815246B2Fc receptor binding proteinsTENHOOR CHRISTOPHER·Filed 2012·Granted Aug 26, 2014·18 cites·12 claims
- 0494US8273351B2Fc receptor binding proteinsTENHOOR CHRISTOPHER·Filed 2009·Granted Sep 25, 2012·20 cites·6 claims
- 0591US9862768B2Methods of producing antibodies to neonatal Fc receptor (FcRn)DYAX CORP·Filed 2016·Granted Jan 9, 2018·7 cites·12 claims
- 0690US11372002B2Assays for determining plasma kallikrein system biomarkersTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Jun 28, 2022·9 cites·15 claims
- 0789US11739152B2Antibodies which bind Fc receptors (FcRn)TAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Aug 29, 2023·1 cites·16 claims
- 0889US11014988B2Nucleic acids encoding anti-neonatal Fc receptor (FcRn) antibodiesDYAX CORP·Filed 2019·Granted May 25, 2021·2 cites·19 claims
- 0988US10479834B2Fc receptor antibodies and methods of use thereofDYAX CORP·Filed 2017·Granted Nov 19, 2019·4 cites·16 claims
- 1088US9359438B2Human neonatal Fc receptor antibodies and methods of use thereofSEXTON DANIEL J·Filed 2012·Granted Jun 7, 2016·9 cites·17 claims
- 1187US12454575B2Nucleic acids encoding FcRn-binding antibodies, pharmaceutical compositions thereof and methods of use thereof to make antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Oct 28, 2025·0 cites·22 claims
- 1287US11156612B2Methods of determining levels of cleaved and/or intact kininogenTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 26, 2021·6 cites·15 claims
- 1383US12384854B2Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedemaTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Aug 12, 2025·1 cites·15 claims
- 1475US12442824B2Assays for determining plasma kallikrein system biomarkersTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Oct 14, 2025·0 cites·9 claims
- 1565US2016222110A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 1665US2013045218A1Fc receptor binding proteinsSYNTONIX PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 1764US2022170936A1Evaluation and treatment of bradykinin-mediated disordersTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1863US2016194397A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 1963US2016222111A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 2063US2016222112A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 2163US2016222109A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 2263US2016222108A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 2352US2009275124A1Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-MMP-14 AntibodiesDYAX CORP·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Tenhoor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →